A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases
Clinical trial NCT04523207 · COMPLETED
Trial details
- NCT number
- NCT04523207
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2023-10-23
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.